1. Home
  2. GTIM vs MDCX Comparison

GTIM vs MDCX Comparison

Compare GTIM & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Good Times Restaurants Inc.

GTIM

Good Times Restaurants Inc.

HOLD

Current Price

$1.51

Market Cap

14.7M

ML Signal

HOLD

Logo Medicus Pharma Ltd.

MDCX

Medicus Pharma Ltd.

HOLD

Current Price

$0.26

Market Cap

15.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTIM
MDCX
Founded
1987
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
15.9M
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
GTIM
MDCX
Price
$1.51
$0.26
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
92.8K
1.8M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$142,315,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.19
N/A
Revenue Growth
3.01
N/A
52 Week Low
$1.10
$0.24
52 Week High
$2.09
$3.05

Technical Indicators

Market Signals
Indicator
GTIM
MDCX
Relative Strength Index (RSI) 55.01 39.66
Support Level $1.36 $0.26
Resistance Level $1.52 $0.36
Average True Range (ATR) 0.07 0.03
MACD -0.00 -0.00
Stochastic Oscillator 40.38 15.62

Price Performance

Historical Comparison
GTIM
MDCX

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants, which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants, which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers, chicken, frozen custard; slides and drinks.

About MDCX Medicus Pharma Ltd.

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

Share on Social Networks: